Hyperferritinemia and markers of inflammation and oxidative stress in the cord blood of HIV-exposed, uninfected (HEU) infants

HIV Medicine

Volumn 16, Issue 6, 2015, Pages 375-380

  Selvam, A ^a   Buhimschi, I A ^b   Makin, J D ^c   Pattinson, R C ^c   Anderson, R ^c   Forsyth, Brian W ^d  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF PRETORIA   (South Africa)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cord blood markers; Ferritin; HIV exposed; Inflammation in HIV infection; Iron status in HIV infection; Oxidative stress in HIV infection; Uninfected (HEU) infants

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIBIOTIC AGENT; C REACTIVE PROTEIN; FERRITIN; BIOLOGICAL MARKER; IL6 PROTEIN, HUMAN; INTERLEUKIN 6; IRON; TRANSFERRIN;

ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; FEMALE; FERRITIN BLOOD LEVEL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERFERRITINEMIA; INFLAMMATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MATERNAL BLOOD; OXIDATIVE STRESS; PREGNANT WOMAN; PREMATURE FETUS MEMBRANE RUPTURE; PRIORITY JOURNAL; UMBILICAL CORD BLOOD; ADULT; BLOOD; CASE CONTROL STUDY; CHEMISTRY; FETUS BLOOD; NEWBORN; PHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION;

ADULT; BIOMARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; FERRITINS; FETAL BLOOD; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; INFLAMMATION; INTERLEUKIN-6; IRON; OXIDATIVE STRESS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; TRANSFERRINS;

EID: 84931464254     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/hiv.12214     Document Type: Article

References (23)

1. UNAIDS. World AIDS Day Report, 2012.
2. Filteau S. The HIV-exposed, uninfected African child. Trop Med Int Health 2009; 14: 276-287.
3. Koyanagi A, Humphrey JH, Ntozini R etal. Morbidity among human immunodeficiency virus exposed but uninfected, human immunodeficiency virus infected and human immunodeficiency virus unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy. Pediatr Infect Dis J 2011; 30: 45-51.
4. Buhimschi IA, Weiner CP. Oxygen free radicals and disorders of pregnancy. Fetal Matern Med Rev 2001; 12: 273-298.
5. Buccigrossi V, Laudiero G, Nicastro E etal. The HIV-1 transactivator factor (Tat) induces enterocyte apoptosis through a redox-mediated mechanism. PLoS ONE 2011; 6: e29436.
6. Gordeuk VR, Onojobi G, Schneider MF etal. The association of serum ferritin and transferrin receptor concentrations with mortality in women with human immunodeficiency virus infection. Haematologica 2006; 91: 739-743.
7. Clark SF. Iron deficiency anemia: diagnosis and management. Curr Opin Gastroenterol 2009; 25: 122-128.
8. Infusino I, Braga F, Dolci A etal. Soluble transferrin receptor (sTfR) and sTfR/log ferritin index for the diagnosis of iron-deficiency anemia: a meta-analysis. Am J Clin Pathol 2012; 138: 642-649.
9. Oliver EA, Buhimschi CS, Dulay AT etal. Activation of the receptor for advanced glycation end products system in women with severe preeclampsia. J Clin Endocrinol Metab 2011; 96: 689-698.
10. Bierhaus A, Humpert PM, Morcos M etal. Understanding RAGE, the receptor for advanced glycation end products. J Mol Med (Berl) 2005; 83: 876-886.
11. Jeong SJ, Kim CO, Song YG etal. Low plasma levels of the soluble receptor for advanced glycation end products in HIV-infected patients with subclinical carotid atherosclerosis receiving combined antiretroviral therapy. Atherosclerosis 2011; 219: 778-783.
12. Kharb S. Total free radical trapping antioxidant potential in pre-eclampsia. Int J Gynaecol Obstet 2000; 69: 23-26.
13. Buhimschi CS, Ali UA, Trotta K etal. Haptoglobin (Hp) switch-on pattern as a biomarker of exposure to intra-amniotic inflammation in twin pregnancies. Am J Obstet Gynecol 2012; 206: S265.
14. Feresu SA, Harlow SD, Gillespie BW etal. Birthweight-adjusted Dubowitz methods: reducing misclassification of assessments of gestational age in a Zimbabwean population. Cent Afr J Med 2003; 49: 47-53.
15. National Department of Health, South Africa. Clinical guidelines: PMTCT (prevention of mother-to-child transmission). South African National AIDS Council. 2010. Accessed at http://www.fidssa.co.za/images/PMTCT_Guidelines.pdf (accessed 22 December 2014).
16. Wong A, Yuen PMP, Li K etal. Cord blood collection before and after placental delivery: levels of nucleated cells, hematopoietic progenitor cells, leukocyte subpopulations and macroscopic clots. Bone Marrow Transplant 2001; 27: 133-138.
17. Buhimschi CS, Dulay AT, Abdel-Razeq S etal. Fetal inflammatory response in women with proteomic biomarkers characteristic of IAI and preterm birth. BJOG 2009; 116: 257-267.
18. Buhimschi IA, Buhimschi CS, Pupkin M etal. Beneficial impact of term labor: nonenzymatic antioxidant reserve in the human fetus. Am J Obstet Gynecol 2003; 189: 181-188.
19. Gordeuk VR, Delanghe JR, Langlois MR etal. Iron status and the outcome of HIV infection: an overview. J Clin Virol 2001; 20: 111-115.
20. Soubasi V, Petridou S, Sarafidis K etal. Association of increased maternal ferritin levels with gestational diabetes and intra-uterine growth retardation. Diabetes Metab 2010; 36: 58-63.
21. Messer RD, Russo AM, McWhirter WR etal. Serum ferritin in term and preterm infants. J Paediatr Child Health 1980; 16: 185-188.
22. Laky CA, Buhimschi IA, Cozzini G etal. Evidence for defective regulated intramembrane proteolysis of the receptor for advanced glycation end products (RAGE) in fetuses with intra-uterine growth restriction (IUGR). Am J Obstet Gynecol 2012; 206: S187-S188.
23. Coffman LG, Parsonage D, D'Agostino JR etal. Regulatory effects of ferritin on angiogenesis. Proc Natl Acad Sci USA 2009; 105: 570-575.